These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25442332)

  • 21. A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report.
    Billingsley CC; Kohler MF; Creasman WT; Madory JE; Young JL
    J Low Genit Tract Dis; 2012 Apr; 16(2):145-8. PubMed ID: 22227838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
    Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study.
    Creasman WT; Zaino RJ; Major FJ; DiSaia PJ; Hatch KD; Homesley HD
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):62-5. PubMed ID: 9465805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
    Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J
    J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer.
    Marnitz S; Köhler C; Füller J; Hinkelbein W; Schneider A
    Strahlenther Onkol; 2006 Jan; 182(1):45-51. PubMed ID: 16404520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of magnetic resonance imaging in pretreatment evaluation of early-stage cervical cancer.
    Zhang W; Zhang J; Yang J; Xue H; Cao D; Huang H; Wu M; Cui Q; Chen J; Lang J; Shen K
    Int J Gynecol Cancer; 2014 Sep; 24(7):1292-8. PubMed ID: 24987919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
    Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
    Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
    Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
    J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients.
    Jung DC; Ju W; Choi HJ; Kang S; Park S; Yoo CW; Park SY
    Eur J Cancer; 2008 Jul; 44(11):1524-8. PubMed ID: 18573655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
    Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
    Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
    Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Uterus corpus extension of primary cervical carcinoma IIA-IIB].
    Smutek J; Wójcik D; Mielnik J; Jurczak-Czaplicka M; Gniadek R
    Ginekol Pol; 2001 Aug; 72(8):618-23. PubMed ID: 11599246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y; Gorchev G
    J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of treatment of 177 stage Ib and IIa cervix cancers at the Zurich University Gynecologic Clinic].
    Hammer F; Schreiner WE
    Gynakol Rundsch; 1989; 29(2):78-92. PubMed ID: 2737539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
    Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.